Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
Clinical trial NCT05251259 · COMPLETED
Trial details
- NCT number
- NCT05251259
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-27
- Primary completion
- 2026-01-07
- Enrollment
- 670
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.